AMs from COPD patients exhibited decreased percentages and levels of phagocytic receptors, such as Fcγ receptor I (FcγRI), macrophage scavenger receptor 1 (MSR1), and Siglec-1 compared to never smokers. This evidence concerns the gene MSR1 and chronic obstructive pulmonary disease.